Ginkgo Bioworks Holdings (DNA) Goodwill (2019 - 2024)
Ginkgo Bioworks Holdings' (DNA) quarterly Goodwill came in at $47.9 million in Q1 2024, up 2077.68% YoY from $2.2 million in Q2 2023, and down 2.7% on a QoQ basis from $49.2 million in Q4 2023.
Ginkgo Bioworks Holdings (DNA) Goodwill (2019 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 6 years of Goodwill data on file, last reported at $47.9 million in Q1 2024.
- Quarterly Goodwill rose 2077.68% year-over-year to $47.9 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $47.9 million (up 2077.68% YoY) and the FY2023 annual result came in at $49.2 million, down 18.22% from the prior year.
- Goodwill eased to $47.9 million in Q1 2024, from $49.2 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $60.2 million in Q4 2022 to a low of $1.9 million in Q4 2020.
- A 5-year average of $25.1 million and a median of $18.1 million in 2021 frame the typical range for Goodwill.
- Annual changes were most pronounced in 2023 — Goodwill tumbled 89.54% — and 2024, when it jumped 2077.68%.
- Tracing DNA's Goodwill over 5 years: stood at $1.9 million in 2020, then surged by 1047.66% to $21.3 million in 2021, then jumped by 182.52% to $60.2 million in 2022, then decreased by 18.22% to $49.2 million in 2023, then slipped by 2.7% to $47.9 million in 2024.
- The last three Goodwill figures came in at $47.9 million (Q1 2024), $49.2 million (Q4 2023), and $58.1 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ginkgo Bioworks Holdings | 432.60 Mn | 348.06 Mn | 18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 47.91 Mn |
| Dec 31, 2023 | 49.24 Mn |
| Sep 30, 2023 | 58.06 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 60.21 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 11.00 Mn |
| Mar 31, 2022 | 21.04 Mn |
| Dec 31, 2021 | 21.31 Mn |
| Sep 30, 2021 | 15.18 Mn |
| Dec 31, 2020 | 1.86 Mn |
| Dec 31, 2019 | 1.86 Mn |